We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TXNM:NYSETXNM Energy, Inc. Analysis

Data as of 2026-09-01 - not real-time

$57.61

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

TXNM Energy, Inc. is priced at $57.61, and its moving averages give no clean directional read — the structure is neutral. With RSI at 52.8 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $57.07 up to resistance at $57.84.
Valuation screens as fair: a P/E of 31.5 sits above the sector average of 19.2. Sell-side targets cluster 5.4% above the current quote. Revenue is growing at 9.2% on a 8.8% profit margin. The 7.95% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 5.0%, a beta of 0.05 and a maximum drawdown of 5.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

Jonathan Ponciano, The Motley Fool Dec 22, 2025 0 Key Points Hong Kong-based Athos Capital added 142,842 shares of TXNM...Seeking Alpha1monTXNM, Blackstone extend merger deadline after regulatory setbackTXNM Energy TXNM and Blackstone...ALBUQUERQUE, N.M., May 29, 2026 /PRNewswire/ -- TNMP, the wholly-owned subsidiary of TXNM Energy NYSE: TXNM in Texas,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 58.43
  • MACD momentum is positive
  • RSI at 52.8 is in neutral territory

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 31.5 versus sector average of 19.2
  • Dividend yield of 7.95% looks stretched against payout coverage
  • Trading below the 200-day average of 58.43

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 31.5 versus sector average of 19.2
  • Dividend yield of 7.95% looks stretched against payout coverage
  • Analyst targets imply +5.4% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin8.77%
P/E Ratio31.5
ROE6.25%
ROA2.26%
Debt/Equity165.51
P/B Ratio1.8
Op. Cash Flow$662.7M
Free Cash Flow$-529223744
Industry P/E19.2

Technical Analysis

TrendNeutral
RSI52.8
Support$57.07
Resistance$57.84
MA 20$57.44
MA 50$57.41
MA 200$58.43
MACDBullish
VolumeIncreasing
Fear & Greed Index93.05

Valuation

Fair Value$26.58
Target Price$60.70
Upside/Downside5.36%
GradeFair
TypeBlend
Dividend Yield7.95%

Risk Assessment

Beta0.05
Volatility4.96%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.